PSYLO-3001

N/A

Report date: 2025/01/26 16:23:57
NME

Base Information

Drug NamePSYLO-3001
Drug Alias NamePSYLO-3001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsAnxiety DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXylo Bio
China Registration ClassN/A

Develop Information

Active CompaniesXylo BioDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A